Detomidine
160 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
160
Total Reports
11
Deaths Reported
690.0%
Death Rate
Active Ingredients
Detomidine
Administration Routes
IntravenousUnknownSublingualPeriodontalOralIntramuscularTopicalSubcutaneousIntra-Arterial
Species Affected
Horse 136
Unknown 8
Dog 7
Human 5
Donkey 3
Cat 1
Most Affected Breeds
Horse (unknown) 34
Quarter Horse 33
Unknown 13
Thoroughbred 10
Arab 7
Paint 6
Horse (other) 5
Tennessee Walking Horse 5
Mixed (Horse) 4
Crossbred Equine/horse 4
Most Reported Reactions
INEFFECTIVE, SEDATION 32
Sedation prolonged 19
Tachypnoea 15
Accidental exposure 13
Ataxia 12
Tachycardia 11
Recumbency 10
Lack of efficacy - NOS 8
Bradycardia 8
Elevated creatinine 8
Collapse (see also 'Cardio-vascular' and 'Systemic disorders') 8
Hyperhidrosis 7
Outcome Breakdown
Recovered/Normal
38 (54.3%)
Outcome Unknown
17 (24.3%)
Euthanized
6 (8.6%)
Died
5 (7.1%)
Ongoing
3 (4.3%)
Recovered with Sequela
1 (1.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.